Marinomed Biotech AG
MARI.VI · VIE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | – | -€6,795 | -€6,398 | -€5,891 |
| Dep. & Amort. | – | €678 | €670 | €609 |
| Deferred Tax | – | €0 | €0 | €0 |
| Stock-Based Comp. | – | €0 | €0 | €0 |
| Change in WC | – | €732 | -€455 | -€810 |
| Other Non-Cash | – | €856 | €980 | €1,226 |
| Operating Cash Flow | – | -€4,528 | -€5,203 | -€4,866 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | – | €0 | -€228 | -€919 |
| Net Acquisitions | – | €0 | €20 | €0 |
| Inv. Purchases | – | €0 | €0 | €0 |
| Inv. Sales/Matur. | – | €0 | €0 | €0 |
| Other Inv. Act. | – | -€129 | €0 | €0 |
| Investing Cash Flow | – | -€129 | -€208 | -€919 |
| Financing Activities | – | – | – | – |
| Debt Repay. | – | -€922 | €7,800 | €2,100 |
| Stock Issued | – | €0 | €0 | €304 |
| Stock Repurch. | – | €0 | €0 | €0 |
| Dividends Paid | – | €0 | €0 | €0 |
| Other Fin. Act. | – | -€7 | -€16 | -€24 |
| Financing Cash Flow | – | -€930 | €7,784 | €2,380 |
| Forex Effect | – | €0 | €0 | €0 |
| Net Chg. in Cash | – | -€5,587 | €2,373 | -€3,405 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | – | €8,175 | €5,802 | €9,207 |
| End Cash | – | €2,589 | €8,175 | €5,802 |
| Free Cash Flow | – | -€4,657 | -€5,431 | -€5,785 |